Clinical Trial Update: Neuromyelitis Optica (NMO) & Cetirizine [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating cetirizine for Neuromyelitis Optica has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica

Drugs mentioned

• Cetirizine (cetirizine)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Neuromyelitis Optica | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-06-07